/    /  Anne Miermont

Anne Miermont


Anne obtained her PhD in Tumor Biology at the University of Georgetown University in Washington DC, USA in 2009, and trained as a postdoctoral fellow at the National Institutes of Health in Bethesda, USA in anti-MEK resistance mechanisms in pancreatic cancer. Anne joined the Federal Agency for Medicinal and Health Products in Brussels, Belgium in 2014 as a non-clinical assessor. She is particularly involved in the assessment of oncological products, at different stages of drug development, including applications for clinical trials in early phase.

User registration

Reset Password